G
Genoptix
Biotech & Life Sciences · Carlsbad, United States · Founded 1999
Provides specialized oncology diagnostics services MoreLess
Genoptix, headquartered in Carlsbad, California, specializes in oncology diagnostic testing services. The company primarily serves physicians and patients in the fight against cancer by providing advanced diagnostic tools and expert analysis. Genoptix operates in the healthcare sector, focusing on hematology and oncology diagnostics. The core service offered is flow cytometry, a technique that uses advanced instruments and laser technology to measure properties of cells and detect cancer cells in samples of bone marrow, blood, or lymph nodes. This process involves treating samples with fluorescent antibodies and scanning them with a laser beam to provide accurate diagnoses.
Genoptix boasts one of the largest teams of board-certified experts in one location, ensuring insightful and timely diagnoses for even the most challenging cases. The company operates a laboratory that is open six days a week and offers after-hours assistance through on-duty Client Services Representatives. Genoptix also provides direct billing to established clients such as hospitals and offers a secure web portal for online invoice review and payment. The company simplifies the billing process with a dedicated team of specialists to assist healthcare professionals and patients with insurance coverage, Medicare coding, and payment options. Additionally, Genoptix handles third-party billing for commercial insurance companies, provided that complete and accurate information is submitted on the test requisition form.
Keywords: oncology, diagnostic testing, flow cytometry, cancer detection, hematology, board-certified experts, direct billing, secure web portal, Medicare coding, third-party billing.
Company overview
Genoptix company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Carlsbad, United States
- Employees
- 142
- Open positions
- None listed
- Dealroom signal
- 65.7
- Investment activity
- 2 companies · latest Dec 2017
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Genoptix funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2011 | $470M | $470M | Novartis | — |
| GROWTH EQUITY VCEquity / VC | Jan 2010 | $0 | — | Hudson River Capital Partners | ↗ |
| IPO✓Exit | Oct 2007 | $85M | $265M | Undisclosed | — |
| SERIES DEquity / VC | Aug 2005 | $17M | $69M | Undisclosed | — |
| SERIES CEquity / VC | Sep 2004 | $3M | $12M | Undisclosed | — |
| SERIES BEquity / VC | Oct 2003 | Undisclosed | — | ||
| SPINOUT✓Other financing | Jan 1999 | University of California, San Diego | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $85M | 0% | 142 |
| 2025 | $85M | 0% | 199 |
| 2024 | $85M | 0% | 199 |
| 2023 | $85M | 0% | 199 |
| 2022 | $85M | 0% | 199 |
| 2021 | $85M | 0% | 209 |
| 2020 | $85M | — | 248 |
Growth signals
Genoptix website traffic
Latest recorded traffic for Genoptix is 200 monthly website visits, down 57.4% over the last three months. Genoptix's team declined 28.6% over the past year.
Comparisons
Genoptix compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Genoptix investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Rosetta GenomicsPrinceton, United StatesDiscovering, developing, and commercializing next generation diagnostic tests for personalized medicine
$30Kvaluation
HistoRxNew Haven, United StatesFinding solutions to the complex problems that arise in the biopharmaceutical industry
$24Mvaluation
Talent graph
Genoptix's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Genoptix has talent and traffic
team presence
In the news
Latest news about Genoptix
Recent press, funding announcements, and product moves mentioning Genoptix — open to read from the original sources.
Market sentiment
What the market is saying about Genoptix
An AI-synthesized read of the highest-engagement posts about Genoptix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genoptix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











